Arcutis Biotherapeutics, Inc. ARQT
27.53 USD -0.85 (-3.00%)
At closeNov 13, 2026, 7:01 AM EST
27.50 -0.03 -0.11%
Pre-market · Nov 13, 7:01 AM ET
27.45 Day range 28.91
19.30 52-week range 34.80
- YTD
- -5.20%
- 1 year
- +17.40%
ARQT revenue history
Revenue is income from the company’s ordinary business activities.
376,072,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 376,072,000 | 179,530,000 | 91.34% |
| FY 2024 | 2024-12-31 | 196,542,000 | 136,936,000 | 229.74% |
| FY 2023 | 2023-12-31 | 59,606,000 | 55,920,000 | 1517.09% |
| FY 2022 | 2022-12-31 | 3,686,000 | 3,686,000 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:01:50.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.